Deadline: 9 October 2019
Applications are open for GCRF global multimorbidity seed-funding which is an Medical Research Council (MRC) initiative that has been developed in collaboration with Wellcome, National Institute for Health Research (NIHR), and Academy of Medical Science (AMS) to support seed-funding projects that develop and test innovative ideas, foster interdisciplinary collaboration, build capacity, and lay the groundwork for future large-scale activity aimed at understanding and tackling multimorbidity in LMICs.
(Ad) Still, finding it difficult to find new grants and donors to support your work? No way to easily search and identify upcoming funding opportunities? No idea how to raise funds? We have a solution for you. Our Premium Membership service answers all your questions. Learn more.
This call will support seed-funding projects in global multimorbidity. Briefly, subject areas may include, but are not limited to:
(Ad) Too many advertisements on this website? Get an ad-free and fully optimized website experience to find grants and donors of your interest. Premium Membership service offers a clean and user-friendly interface for you to raise funds successfully! Learn more.
- Preliminary data collection and methodological development to understand behavioural, environmental, sociodemographic, and biological factors associated with common clusters/clusters of highest burden and determinants of discordant co-occurring conditions.
- Audit and analysis of existing data to either: i) bring together the fragmented evidence base caused by variations in definition and classification of multimorbidity, ii) utilise existing cohort/surveillance data to identify trends and modifiable risk factors, iii) examine healthcare costs associated with different clusters of conditions and models of care, or iv) assess the impact of existing primary prevention strategies on multimorbidity.
- Feasibility (including acceptability) and pilot work towards the development of primary (e.g., lifestyle interventions), secondary (e.g., preventing multimorbidity once one condition has been diagnosed, polypharmacy effects), and tertiary (e.g., integrated management, mHealth) prevention strategies across all age groups.
- Establishing foundations for studies focused on understanding trends in multimorbidity. Seed-funding would also enable the follow up of previous studies to enable longitudinal or repeated cross-sectional analysis.
- Development of sensitive measures to determine the impact on quality of life for patients and carers of living with multimorbidity.
- Capacity building, networking, and connection of existing resources within LMICs to allow interdisciplinary investigation of multimorbidity.
Funding Information and Duration
- The MRC has made £2.5 million available for seed-funding in global multimorbidity through this call.
- PIs may apply for seed-funding up to 18 months in duration. Applications should not exceed £200,000 and in some cases may be substantially less.
- Grants are intended to support:
(Ad) Premium Membership offers unlimited search options to find your grants and donors. Search by country or thematic area of your work interest or even by keyword. View the number of open grants for your country. on a Google Map. Keep a watch on grant deadlines through a calendar. Learn more.
- The research must be primarily aimed at tackling multimorbidity in LMICs. UK or HIC-focused applications are not eligible for this call and will be rejected prior to review.
- The PI is the lead researcher on the application with overall responsibility for the intellectual leadership of the project and for the overall management of the research. The grant will be administered by the PI’s Research Organisation. Co-Is assist the PI in the management and leadership of the research and may provide specialist expertise in a particular facet of the research.
- PI’s should be based at an eligible LMIC or UK Research Organisation.
- Research into multimorbidity and health systems/health services should be rooted in the context where it will take place with strong engagement with policy makers to maximise potential uptake of the research findings.
- Applications involving industrial collaborators are eligible and should follow the MRC Industry Collaboration Agreement (MICA) process. Industrial collaborators cannot be recipients of funding and must be listed as Project Partners or sub-contractors.
How to Apply
Applicants can apply online via given website.
(Ad) Too many emails about grants, but too few leads? Join Premium and use our Specific Email Alerts feature where you can select your country/countries and thematic areas of work interest and receive grant information accordingly. Learn more.
For more information, please visit https://mrc.ukri.org/funding/browse/gcrf-gmsf/gcrf-global-multimorbidity-seed-funding-2019/